Moore Capital Management’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.85M Sell
193,045
-81,618
-30% -$2.78M 0.11% 165
2026
Q2
$8.72M Buy
274,663
+77,355
+39% +$2.29M 0.13% 143
2026
Q1
$5.95M Buy
+197,308
New +$6.38M 0.12% 138

Other funds holding IMCR

Moore Capital Management's IMCR Position: Q3 2026 in Review

Moore Capital Management reduced its Immunocore (IMCR) stake by 30% in Q3 2026, selling an estimated $2.78M and leaving 193,045 shares worth $5.85M. The position accounts for 0.11% of the portfolio, ranked #165.

Moore Capital Management first reported a position in IMCR in Q1 2026 and has held it in 3 quarters since. The position peaked at $8.72M in Q2 2026. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • Moore Capital Management held 193,045 shares of Immunocore worth $5.85M as of Q3 2026.
  • Moore Capital Management sold 81,618 Immunocore shares in Q3 2026, an estimated $2.78M.
  • Immunocore made up 0.11% of Moore Capital Management's portfolio in Q3 2026, its #165 holding.
  • Moore Capital Management first reported a position in Immunocore in Q1 2026 and has held it in 3 quarters since.
  • Moore Capital Management's Immunocore position peaked at $8.72M in Q2 2026.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Moore Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.